Recalls & Warnings March 29, 2020 Seller of "Immune Tonic" Warned for Making Coronavirus Claims On March 26, 2020, the FDA issued a warning letter to Carahealth for selling products with unsupported claims that they can treat coronavirus (COVID-19)
Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced [PMID: 21295044] Laboratory literature summary: Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions
You can't sell it as a supplement, actually, um, the way that it has been sort of
It is important to note, however, that in the case of medicines administered by injection, the MHRA is governed also by the foundational Medicines Act 1968 (now largely embodied in the Human Medicines Regulations 2012 )